Abhita Batra, a young and visionary scientist - turned Chief Executive Officer - is on a quest to successfully re-imagine patient experience
The world is changing quickly and that is no secret. New technologies continue to emerge as society itself struggles to adapt to the “new normal”. Upon taking a closer look at the life sciences and healthcare market, it is not difficult to acknowledge that millions of patients have been burdened (for too long) by outdated and obsolete procedures.
People from all walks of life can attest to the strain that certain treatments are known to cause - particularly invasive procedures that have been historically used to treat delicate and complex conditions (mostly hearing and vision related) – such treatments are beginning to seem like a thing of the past. On a global scale, devoted researchers and the unwavering commitment exhibited by them on a daily basis have fueled a series of tremendously impactful and deeply promising innovations.
Within the burgeoning field of biotechnology, a particular figure stands out.
Abhita Batra, a young and visionary scientist – turned Chief Executive Officer – is on a quest to successfully re-imagine patient experience. By championing a groundbreaking style of ultra targeted, non invasive magnetic payload delivery technology with virtually unlimited healthcare potential (including a range of highly promising solutions focused on pro-active COVID-19 counter attack) - Batra has effectively cemented her company´s reputation as one of the pre-eminent market makers of a new and improved biotech sector that holds the promise of improved quality of life for millions around the world.
The story - wind back to early 2016, Abhita was introduced to an innovative new magnetic drug delivery technology, originally developed at the University of Maryland out of the Fischell Department of BIoengineering (BioE) and Institute for Systems Research.
This technology, which non-invasively directs biocompatible nanoparticles and their therapeutic payloads through soft tissue, immediately captured her interest and passion; After doing her own due diligence with leading medical experts, Batra confidently assumed her duties as CEO; Since then, the company has raised funding from a number of sources. As recently reported by Yahoo Finance: “Under Abhita Batra´s efficient leadership, Otomagnetics has successfully raised several million dollars in seed capital and secured a myriad of strategic commercial and development partnerships.” - Expert analysts have stated: “what excites investors and clinicians alike is the potential to solve an unmet clinical need.”